Navigation Links
SkelRegen Welcomes Director of Scientific Affairs to Management Team

WEST CHESTER, Pa., April 23, 2013 /PRNewswire/ -- SkelRegen, LLC, the leader in small molecule musculoskeletal tissue regeneration and the first to identify multiple small molecules that are osteoinductive and target different aspects of the musculoskeletal tissue formation pathway, today announced the hire of John M. Wozney, Ph.D. as Director of Scientific Affairs and Co-Owner. In his role at SkelRegen, Wozney will set experimental design and direction; lead collaboration with development partners; build alternative R&D pathways; and optimize project quality, cost and time variables.  

Wozney is an internationally recognized expert in the key-signaling molecules involved in the growth and maintenance of bone and soft tissues called bone morphogenetic proteins (BMPs), and musculoskeletal biology. He joins the SkelRegen team from the Genetics Institute (acquired by Wyeth and subsequently Pfizer), where he conducted research leading to the identification of BMP. He then played a key role in the commercialization of a genetically engineered protein (rhBMP-2) and the development of a local delivery system as an innovative bone-inductive therapeutic, which has found widespread use in orthopaedics.

In his role at SkelRegen, Wozney brings more than 25 years' experience in the pharmaceutical industry and scientific leadership to help grow the company as it leads the way in small molecule musculoskeletal tissue regeneration. "John brings a unique set of skills, experience and perspective to our business and we are delighted to have him join the team," said Stephen R. La Neve, SkelRegen's Co-Founder and CEO. "His accomplishments, reputation and understanding of our business will help SkelRegen bring our game-changing technologies to the bedside, and strengthen our business of small molecule musculoskeletal tissue regeneration."

"John's knowledge and proficiency in orthobiologics builds on the strength of SkelRegen's value proposition," said SkelRegen Co-Founder and Chief Medical, Science and Technology Officer, Scott D. Boden, M.D. Boden is Chief Medical Officer and Director of the Emory University Orthopaedic & Spine Hospital and Professor of Orthopaedics, Emory University School of Medicine. "As Director of Scientific Affairs, John will ensure that SkelRegen's platform of small molecule technologies for transforming musculoskeletal care continues to provide cutting-edge solutions for those in orthopaedic surgery, trauma and plastic surgery."

"I am thrilled to be part of the SkelRegen team," said John Wozney. "As someone who has been in the industry for almost three decades, I am sure the work that SkelRegen is doing right now is leading the way in orthopaedic small molecule technology and I'm proud to be part of this revolutionary approach to musculoskeletal tissue regeneration."

Wozney is the author of more than 150 peer-reviewed publications and is an inventor on more than 50 issued U.S. patents. He received both his A.B. and Ph.D. degrees in biochemistry from Harvard University and was a post-doctoral fellow at Massachusetts Institute of Technology.

About SkelRegen

SkelRegen, LLC was formed in the state of Delaware in September 2012.  The company maintains its headquarters in West Chester, PA.  For more information on the company, its products, or investment opportunities, please visit the company's website at or call the company's media contact directly.

Contact:  Shannon Webber
(412) 749-9299 x103

This press release was issued through eReleases® Press Release Distribution. For more information, visit

SOURCE SkelRegen
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Chesapeake Urology Associates Welcomes Dr. Anup R. Shah
2. Paradigm Spine Welcomes Hallett Mathews, MD, MBA As Its Executive Vice President & Chief Medical Officer
3. Sequenom Welcomes Myla Lai-Goldman, M.D., To Board Of Directors
4. Thomson Reuters Welcomes Inova Software to Its Partner Ecosystem for Life Sciences
5. Draeger Welcomes NIOSH Investigation Report
6. Oriel STAT A MATRIX Welcomes New Global Practice Head for Medical Devices and Life Sciences
7. Global BioClinical Welcomes Jennifer Maas as Senior Consultant
8. SOCMAs Bulk Pharmaceuticals Task Force Welcomes House Passage of FDA Reform Act
9. SCOLR Pharma Welcomes Clem Calabrese as Director of Field Sales
10. Venaxis Appoints SomaLogic CMO and former Pfizer Executive Stephen A. Williams, M.D., Ph.D., to Board of Directors
11. Randy Hill Appointed to Vasomedical Board of Directors
Post Your Comments:
(Date:11/26/2015)... 2015 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ... demands kidney transplantation is expected to boost the market growth, ... organ transplantation. --> 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... ) has ... Future Horizons and Growth Strategies in the ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> ) has announced the ... and Growth Strategies in the German Drugs ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... A team of Swiss doctors has released a report on ... just posted the findings on the website. Click here to read the details ... mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among the 106 ...
(Date:11/27/2015)... ... ... Lizzie’s Lice Pickers just announced a special promotion that will run throughout ... of lice treatment product. In addition, customers will receive a complimentary head Check when ... is a sure way to ruin the holidays, so we encourage all of our ...
(Date:11/27/2015)... ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that ... ). More than 3.7 billion people under the age of 50 – or 67% ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices in ... that delves into an array of issues that are presently affecting Americans. Dedicated to ... dialogue, this show is changing the subjects consumers focus on, one episode at a ...
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... the Commission on Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its ... exclusive list of CAAHEP accredited colleges, as only one of twelve colleges and universities ...
Breaking Medicine News(10 mins):